FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA | FDA Centennial
Public Law 107-109
January 4, 2002
Table of Contents
Section 2. Pediatric Studies of Already-Marketed Drugs
Section 3. Research Fund for the Study of Drugs
Section 5. Timely Labeling Changes for Drugs Granted Exclusivity; Drug Fees
Section 6. Office of Pediatric Therapeutics
Section 9. Dissemination of Pediatric Information
Section 12. Study Concerning Research Involving Children
Section 13. Foundation for the National Institutes of Health
Section 14. Pediatric Pharmacology Advisory Committee
Section 15. Pediatric Subcommittee of the Oncologic Drugs Advisory Committee
Section 16. Report on Pediatric Exclusivity Program
Section 17. Adverse-Event Reporting
Section 18. Minority Children and Pediatric-Exclusivity Program